Cargando…

Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of complications in type 1 diabetes (T1DM) patients. To date, several biochemical indexes of NAFLD have been developed. Among these, hepatic steatosis index (HSI) strongly relates with the results of magneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripolino, Cesare, Irace, Concetta, Cutruzzolà, Antonio, Parise, Martina, Barone, Milena, Scicchitano, Caterina, Cortese, Claudio, Gnasso, Agostino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875487/ https://www.ncbi.nlm.nih.gov/pubmed/31819566 http://dx.doi.org/10.2147/DMSO.S221969

Ejemplares similares

Autoimmune thyroiditis and celiac disease do not worsen endothelial function in subjects with type 1 diabetes: an observational study
por: Parise, Martina, et al.
Publicado: (2022)

Effect of Extra Virgin Olive Oil and Butter on Endothelial Function in Type 1 Diabetes
por: Cutruzzolà, Antonio, et al.
Publicado: (2021)

Effect of empagliflozin on brachial artery shear stress and endothelial function in subjects with type 2 diabetes: Results from an exploratory study
por: Irace, Concetta, et al.
Publicado: (2019)

The Effect of Two Different Insulin Formulations on Postprandial Hyperglycemia after High and Low Glycemic-Index Meal in Type 1 Diabetes
por: Cutruzzolà, Antonio, et al.
Publicado: (2022)

Diabetes Data Management System to Improve Glycemic Control in People With Type 1 Diabetes: Prospective Cohort Study
por: Irace, Concetta, et al.
Publicado: (2017)

A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study
por: Parise, Martina, et al.
Publicado: (2023)

Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy
por: Irace, Concetta, et al.
Publicado: (2018)

Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study
por: Parise, Martina, et al.
Publicado: (2021)

Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes
por: Irace, Concetta, et al.
Publicado: (2019)

Serum Calcium Increase Correlates With Worsening of Lipid Profile: An Observational Study on a Large Cohort From South Italy
por: Gallo, Luigia, et al.
Publicado: (2016)

Continuous Glucose Monitoring-Derived Metrics and Capillary Vessel Density in Subjects with Type 1 Diabetes without Diabetic Retinopathy
por: Cutruzzolà, Antonio, et al.
Publicado: (2023)

Periodontal Treatment Elevates Carotid Wall Shear Stress in the Medium Term
por: Carallo, Claudio, et al.
Publicado: (2015)

Evidence for congruent impairment in micro and macrovascular function in type 1 diabetes
por: Irace, Concetta, et al.
Publicado: (2017)

Functional and morphological cardiovascular alterations associated with neurofibromatosis 1
por: Cutruzzolà, Antonio, et al.
Publicado: (2020)

Management of Type 2 Diabetes Mellitus through Telemedicine
por: Carallo, Claudio, et al.
Publicado: (2015)

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes
por: Irace, Concetta, et al.
Publicado: (2020)

Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index
por: Johnson, Stephen I., et al.
Publicado: (2021)

Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes
por: Wang, Chenxi, et al.
Publicado: (2021)

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
por: Riemann, Annika, et al.
Publicado: (2022)

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
por: Bedogni, Giorgio, et al.
Publicado: (2006)

The Interaction between Diabetes, Body Mass Index, Hepatic Steatosis, and Risk of Liver Resection: Insulin Dependent Diabetes Is the Greatest Risk for Major Complications
por: Wiggans, M. G., et al.
Publicado: (2014)

Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population
por: Khani, Vahid, et al.
Publicado: (2022)

Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis
por: Hong, Alex S, et al.
Publicado: (2022)

Interest of hepatic steatosis index (HSI) in screening for metabolic steatopathy in patients with type 2 diabetes
por: Fennoun, Halima, et al.
Publicado: (2020)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Is hepatic steatosis associated with left ventricular mass index increase in the general population?
por: Piontek, Katharina, et al.
Publicado: (2017)

Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis
por: Chang, Jae Seung, et al.
Publicado: (2022)

A Significant Effect of Pemafibrate on Hepatic Steatosis and Fibrosis Indexes in Patients With Hypertriglyceridemia
por: Katsuyama, Hisayuki, et al.
Publicado: (2023)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Case Report: High-concentration Insulin Glargine Overdose Complicated by Hepatic Steatosis
por: Endall, Ryan, et al.
Publicado: (2020)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Hepatic steatosis in patients with acromegaly
por: Koutsou‐Tassopoulou, Andreani, et al.
Publicado: (2019)

Insulin overdose complicated by treatment‐induced acute hepatic steatosis in a nondiabetic patient
por: Okamoto, Noriyuki, et al.
Publicado: (2022)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes
por: Reginato, Elisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9turjqq7h9vnpcom2r2dukl8fv